Inmune Bio, Inc. (INMB) › Weighted Average Diluted SharesInmune Bio, Inc. (INMB) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 16.13M2022-12-31: 17.93M2023-12-31: 17.98M2024-12-31: 19.94M2025-12-31: 24.76M24.76M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3124.76M+24.1%2026-03-30From 2025-01-012024-12-3119.94M+10.9%2026-03-30From 2024-01-012023-12-3117.98M+0.3%2025-03-27From 2023-01-012022-12-3117.93M+11.1%2024-03-28From 2022-01-012021-12-3116.13M—2023-03-02From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)